Deciphering Crosstalk Pathways in EGF-Induced Cell Signaling Networks

Cell signaling via epidermal growth factor (EGF) is a critical process in regulating cellular proliferation, differentiation, and migration. The objective of this study was to elucidate the intricate crosstalk between EGF-initiated signaling pathways in human epithelial cells. Using advanced proteomic techniques combined with CRISPR-based gene editing, we dissected the downstream effects of EGF stimulation on key signaling molecules. Our methods included mass spectrometry to quantify protein phosphorylation states and high-throughput screening to identify functional interactions. We discovered that EGF significantly enhances phosphorylation of MAPK and PI3K/AKT pathways, with a simultaneous upregulation of Ras-related C3 botulinum toxin substrate (RAC1) activity, leading to enhanced cellular motility. Quantitative analysis revealed a 2.5-fold increase in RAC1 activity upon EGF treatment (p < 0.01). Furthermore, we identified a novel role for the adaptor protein GAB1 in facilitating crosstalk between these pathways, crucial for signal amplification. Our findings suggest that the modulation of GAB1 could serve as a potential therapeutic target to control aberrant cellular responses in cancer. Conclusively, this study expands our understanding of EGF-mediated signaling networks and their implications in cell biology and oncology.